This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Treatment of Locally Advanced Non-Small Cell Lung ...
Clinical trial

Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Read time: 1 mins
Last updated:28th Jan 2010
The purpose of this study is to determine the maximum tolerated dose of the combination of vorinostat, cisplatin, pemetrexed, and radiation therapy in patients with unresectable stage IIIA/IIIB non-small cell lung cancer.
Category Value
Study start date 2010-01-28

View full details